[The determination of catalase activity in liver tissue (author's transl)]

Wittrin G, G Wittrin, H G Horstmann, Horstmann HG, Hunger J, J Hunger, Schnieder G, G Schnieder
Klinische Wochenschrift · 1975 · vol. 53(15) , pp. 723–5 · doi:10.1007/bf01468704 · PMID:1219184
Observational OA: closed
View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-19 ⓘ

Spectrophotometric measurement of catalase activity in liver tissue revealed significantly lower levels in patients with carcinoma compared to controls, although pathological liver findings or inflammatory diseases also resulted in reduced activity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In 31 patients with carcinoma and 45 controls catalase activity of liver tissue was measured spectrophotometrically. In patients with carcinoma the activity was significantly lower. Within the control group patients with pathological liver findings or inflammatory disease of the pancreas or bile ducts showed a relatively low catalase activity which are obviously higher than in patients with carcinoma.

My notes (saved in your browser only)

MeSH descriptors

Catalase Liver Biliary Tract Diseases Biliary Tract Diseases Catalase Humans Liver

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:00:38.508852+00:00